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a  b  s  t  r  a  c  t
Chinese  hamster  ovary  (CHO)  cells represent  the  most  commonly  used  production  cell  line  for  therapeutic
proteins.  By  recent  genome  and transcriptome  sequencing  a basis  was  created  for future  investigations  of
genotype–phenotype  relationships  and for improvement  of  CHO  cell  productivity  and  product  quality.  In
this context  information  is missing  about  DNA  cytosine  methylation  as  a crucial  epigenetic  modiﬁcation
and  an  important  element  in  mammalian  genome  regulation  and  development.  Here,  we  present  the
ﬁrst DNA  methylation  map  of a CHO  cell  line  in  single-base  resolution  that  was  generated  by  whole
genome  bisulﬁte  sequencing  combined  with  gene  expression  analysis  by CHO  microarrays.  We  show  CHO
DP-12 cells  to  exhibit  global  hypomethylation  compared  to  a majority  of mammalian  methylomes  andNA methylation
hole genome bisulﬁte sequencing
ene expression
hypermethylation  of  CpG-dense  regions  at  gene  promoters  called  CpG  islands.  We  also  observed  partially
methylated  domains  that  cover  62% of  the  CHO  DP-12  cell  genome  and  contain  functional  clusters  of
genes.  Gene  expression  analysis  showed  these  clusters  to be either  highly  or weakly  expressed  with
regard  to CHO-speciﬁc  characteristics  and  hence  proves  DNA methylation  in  CHO  cells  to  be an important
link  between  genomics  and transcriptomics.
© 2015  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Chinese hamster ovary (CHO) cells are the major mam-
alian production cell line for therapeutic proteins. Therefore
mprovement of CHO-based bioprocess performance and product
haracteristics of biopharmaceutics, e.g. by molecular engineering
pproaches, is of great interest to academia and industry (Baik and
ee, 2014). An essential basis for this purpose is the CHO K1 genomic
equence and transcriptome data that became recently available
nd will enable a deeper understanding of genotype–phenotype
elationships in terms of product quality attributes (Baik and Lee,
014; Lewis et al., 2013; Rupp et al., 2014). A missing link between
hese cellular levels in CHO cells, however, is the yet unknown CHO
ell epigenome.The term epigenetics classically describes phenomena that
odify gene expression without altering the DNA sequence.
t comprises posttranslational histone modiﬁcations, chromatin
∗ Corresponding author at: Bielefeld University, Universitätsstraße 25, 33615
ielefeld, Germany. Tel.: +49 521 106 8700; fax: +49 521 106 6023.
E-mail address: thomas.noll@uni-bielefeld.de (T. Noll).
ttp://dx.doi.org/10.1016/j.jbiotec.2015.02.014
168-1656/© 2015 The Authors. Published by Elsevier B.V. This is an open access article unlicense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
remodeling and DNA methylation (Ndlovu et al., 2011; Tessarz
and Kouzarides, 2014). Furthermore, miRNAs were shown to be
involved in epigenetic regulation, e.g. by double-negative feed-
back loops (Osella et al., 2014). DNA methylation has been known
since the 1970s (Holliday and Pugh, 1975; Riggs, 1975) and was
shown to contribute to processes of irreversible gene silencing
such as X chromosome inactivation or silencing of retrotransposons
(Bestor et al., 2014; Panning and Jaenisch, 1996; Walsh et al., 1998).
DNA methylation takes place at cytosine bases in the context of
CpG dinucleotides and effects the majority of vertebrate genomes,
which for the most part contain only few regions of low methyla-
tion (Meissner et al., 2008). These regions include e.g. CpG-dense,
often unmethylated areas at gene promoters called CpG islands
(CGIs) that have been extensively studied in locus-speciﬁc exper-
iments (Deaton and Bird, 2011; Illingworth and Bird, 2009). The
advent of next generation sequencing technologies enabled an
in-depth mapping of the distribution of DNA methylation on a
genome scale for several mammalian tissues and cell types. This
led, for instance, to the discovery of global differences between
the genomes of human embryonic stem cells and fetal ﬁbroblasts
regarding the composition and patterning of DNA methylation
(Lister et al., 2009). Fibroblast cells turned out to be characterized
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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y widespread reduced methylation associated with less actively
ranscribed genes and represented the ﬁrst cell line shown to con-
ain so-called partially methylated domains (PMDs) as an exception
o the notion of generally highly methylated mammalian genomes
Gaidatzis et al., 2014).
Several reports hint toward an inﬂuence of epigenetic effects on
roduct gene expression in CHO-based bioprocesses, e.g. regarding
ntragenic CpG content of transgenes (Bauer et al., 2010) and
MV promoter methylation (Kim et al., 2011; Yang et al., 2010;
sterlehner et al., 2011). To analyze DNA methylation in CHO
ells, we recently developed a CpG island microarray and showed
ifferential DNA methylation in response to butyrate treatment
Wippermann et al., 2013). However, a comprehensive under-
tanding of epigenetic effects in biopharmaceutics production as
n important link between genotype and phenotype requires a
lobal characterization of the yet unknown CHO cell epigenome.
n this study the DNA methylation landscape of IgG-producing
HO DP-12 cells was characterized and putative inﬂuences of the
ethylation landscape on gene expression were analyzed. For
his purpose we applied whole genome bisulﬁte sequencing in
ombination with gene expression analyses by custom-designed
HO-speciﬁc microarrays (Becker et al., 2014). We  show that the
lobally hypomethylated CHO DP-12 cell genome contains hyper-
ethylated CGIs and regions of partial methylation that contain
unctional gene clusters expressed in a differential fashion.
. Materials and methods
.1. Cell culture and cultivation process analysis
IgG-producing CHO DP-12 cells (clone#1934, ATCC CRL-12445)
ere cultivated in CHOMACS CD medium (Miltenyi Biotec, Ber-
isch Gladbach, Germany) supplemented with 6 mM l-glutamine
Fagron GmbH & Co. KG, Barsbüttel, Germany), 200 nM methotrex-
te (MTX; Wyeth, Madison, NJ) and 0.1 mg  × L−1 Insulin-like
rowth factor (Long R3 IGF-I; Sigma–Aldrich, Munich, Germany).
ells were cultivated in 250 mL  shaker ﬂasks (Corning Inc., Corning,
Y) with a seeding cell density of 1 × 106 cells × mL−1. Four repli-
ate cultures were prepared from one preculture. Culture ﬂasks
ere kept at 37 ◦C, 80% humidity and 5% CO2 on a shaking platform
t 185 rpm (50 mm diameter rotation). Two days after inoculation
amples of 6.5 × 106 cells were taken for DNA and RNA extractions.
easurements of cell densities and viabilities were performed on
 Cedex AS20 cellcounter (Innovatis AG, Bielefeld, Germany). IgG
oncentrations were measured with a HPLC method on protein A
olumns according to the manufacturer’s protocol (Poros A, Applied
iosystems, Foster City, CA). Glucose and lactate concentrations
ere measured on an YSI 2700 Select Analyzer (Yellow Springs
nstruments Inc., Yellow Springs, OH).
.2. Library construction and sequencing
Replicate samples were pooled and genomic DNA was  extracted
rom 2.6 × 107 CHO DP-12 cells using a DNeasy Blood & Tissue Kit
Qiagen, Venlo, The Netherlands). 50 ng of extracted DNA were
piked with 0.01% (w/w) of unmethylated cl857 Sam7 Lambda DNA
Promega, Madison, WI)  that served as an unmethylated control
nd was subjected to bisulﬁte treatment (ZymoResearch Methyl-
tion Lightning Kit; ZymoResearch, Irvine, CA). Bisulﬁte converted
NA was stored at −80 ◦C until library construction. Library
eneration from bisulﬁte treated DNA and 10 ng of unconverted
enomic DNA was performed using the EpiGnome Methyl-Seq
it (Epicenter, Madison, WI)  according to the manufacturer’s
nstructions. To allow for multiplexed sequencing of libraries
rom bisulﬁte treated and native DNA, individual libraries weretechnology 199 (2015) 38–46 39
barcoded using EpiGnome Index PCR Primers (Epicenter). The
quality of both libraries was  checked on High Sensitivity DNA
Chips on the Bioanalyzer (Agilent Technologies, Santa Clara, CA).
Paired-end sequencing was performed on an Illumina HiSeq 1500
system in a 2 × 100 bp run with 1% PhiX Control v3 (Illumina) in
each lane. One entire lane was  used as a control to sequence the
unconverted CHO DP-12 genomic DNA library and to allow for
phasing and pre-phasing. Lanes containing bisulﬁte libraries were
additionally loaded with 10% of the unconverted DNA library.
2.3. Bioinformatics analysis of sequencing data
Paired-end reads were quality checked using FastQC (Andrews,
2010) and trimmed using Trimmomatic (Bolger et al., 2014). The
reference CHO K1 genome (Xu et al., 2011) was corrected for single
nucleotide polymorphisms (SNPs) within the CHO DP-12 cell line.
First the reads from the sequencing of unconverted CHO DP-12 DNA
were mapped to the CHO K1 genome with Bowtie2 (Langmead and
Salzberg, 2012). SNPs were then called using the samtools mpileup
algorithm (Li et al., 2009) and ﬁltered using in house perl scripts.
SNPs with a minimal coverage of 4 reads and at least 25% of the
reads containing the SNP were used for cell line correction using
the vcfutils vcf2fq method. The Smithlab Methylation Data Analy-
sis Pipeline (Song et al., 2013) was used for mapping of reads from
bisulﬁte treated libraries to the SNP-corrected reference genome,
removal of duplicate reads, calculation of single-site methylation
levels, estimation of bisulﬁte conversion rates and calculation of
methylation levels in untranslated regions (UTRs), exons, introns
and CGIs (annotation of CGIs based on Wippermann et al., 2013).
Methylation data tracks were integrated into the in-house GenDBE
genome browser (Rupp et al., 2014) to inspect selected regions with
known methylation patterns for accordance of WGBS results. For
this, branched chain amino acid aminotransferase cytosolic-like gene,
Bcat1 (GeneID 100763658), served as a methylated control. The
beta-actin gene, Actb (GeneID 100689477), served as an unmethy-
lated control. Partially methylated domains (PMDs) of more than
10 kb and methylation levels below 70% were identiﬁed using a
sliding window approach according to Lister et al. (2009). For this,
SNP-corrected CHO K1 scaffolds containing more than 100 CpGs
were included into the analysis (5874 scaffolds comprising 96%
of the CHO genome). For PMDs and hypermethylated domains
(HMDs) with >100 CpGs, average methylation levels, size and cov-
erage by coding sequence (CDS) were analyzed. Assignment of CHO
DP-12 PMDs to the recently sequenced Chinese hamster (CH) chro-
mosomes (Brinkrolf et al., 2013) was based on read coverages.
2.4. Gene expression proﬁling by microarrays
Total RNA was extracted from 6.5 × 106 cells per replicate
culture using the Direct-zol RNA MiniPrep Kit (ZymoResearch).
Puriﬁed RNA samples were quantiﬁed on a NanoPhotometer
(IMPLEN, Munich, Germany). Integrity of RNA was checked on
denaturing agarose gels stained with GelRed (Biotium Inc., Hay-
ward, CA) and visualized on a Fusion XL7 (Vilber, Eberhardzell,
Germany). RNA samples were pooled and analyzed by 4 × 44 K
one-color microarrays (Agilent Technologies). Labeling and
hybridization of four replicate custom designed CHO microarrays
was performed as described in Becker et al. (2014). Array quality
was estimated based on the resulting QC reports and plots of
raw data. Data analysis was  subsequently performed using the
limma  package in R (Smyth, 2005) after background correction and
quantile normalization across the technical replicates. For the eval-
uation of our whole genome bisulﬁte sequencing data we aimed
to collect the subset of genes highly expressed in our samples.
All genes with expression values above the 75th percentile were
deﬁned as highly expressed (according to Schroeder et al., 2011).
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Fig. 1. Cell growth, IgG production, glucose and lactate concentrations of CHO DP-12
cell  cultures. Error bars represent standard deviations of four replicate cultures. The
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1ertical line marks the sampling point for whole genome bisulﬁte sequencing and
ene expression analysis. (A) Mean viability (Viab), cell speciﬁc productivity (qp)
nd  viable cell density (VCD). (B) Glucose (Glc) and lactate (Lac) concentrations.
ene Ontology annotations were performed using the DAVID
oftware (Huang et al., 2009) with EASE scores of <0.1 and FDR
orrection of p values according to Benjamini and Hochberg (1995).
. Results
.1. Generation of the base-pair-resolution CHO DP-12 DNA
ethylation map
Replicate (n = 4) batch cultures were monitored regarding viable
ell density, viability, cell speciﬁc productivity (Fig. 1A), glucose
onsumption and lactate formation (Fig. 1B) to account for optimal
rowth and production behavior. The cultures showed normal cell
rowth with a maximum viable cell density seven days post inoc-
lation and high viabilities until glucose depletion. When glucose
as limited on day eight the cells started to metabolize lactate.
amples were taken in the middle of the exponential growth phase
hen the cells exhibited a viability of 99% and a cell speciﬁc pro-
uctivity of 7.4 pg/cell × d.
Replicate samples were pooled prior to extraction of DNA for
nalysis by whole genome bisulﬁte sequencing. Isolated genomic
NA was treated with bisulﬁte, which led to the conversion
f unmethylated cytosines to uracil bases, whereas methylated
ytosines remained intact. As the CHO DP-12 genome sequence is
ot available yet, sequencing reads from bisulﬁte treated libraries
ere mapped to the CHO K1 genome. For this, a second library
as generated from untreated genomic CHO DP-12 DNA to account
or SNPs present between the two genomes. Both libraries were
ubjected to next generation Illumina sequencing. After trimming
f paired-end sequencing reads we obtained 66.2 Gb (402,802,819
eads) of sequence information for the bisulﬁte treated CHO DP-
2 DNA and 95.8 Gb (575,986,927 reads) for the unconverted CHOtechnology 199 (2015) 38–46
DP-12 genome. 84% of the latter could be mapped to the CHO K1
reference genome and 74% were properly paired. SNP detection
showed 4,054,041 SNPs in the CHO DP-12 genome compared to
the CHO K1 cell line.
In the next step, reads from bisulﬁte treated libraries were
mapped to the SNP-corrected CHO K1 genome. This resulted in
an average sequencing depth of 14-fold with 94% of all known
CpG sites covered (15.3 million CpGs). Subsequently, methylation
levels for each CpG dinucleotide within the CHO DP-12 genome
were determined by calculating the ratio of mapped thymines (as
uracil is ampliﬁed as thymine) and cytosines at individual CpG
positions. To evaluate the quality of the sequencing data and the
correctness of its processing, CHO DP-12 cell genomic regions with
known methylation levels were compared to previous experiments
to check for consistency (according to Wippermann et al., 2013). For
this purpose a region located within the promoter CpG island of
the branched chain amino acid aminotransferase cytosolic-like gene
(Bcat1) served as a methylated control (Supplementary Fig. S1A).
Part of the 5′ UTR-associated CpG island of the beta-actin gene (Actb)
served as an unmethylated control (Supplementary Fig. S1B). Both
regions exhibited the expected methylation levels. Also, the quality
of bisulﬁte conversion was controlled by calculating the conversion
rate of the spike-in Lambda DNA, which was above 99%.
3.2. Global assessment of the CHO DP-12 DNA methylation
landscape
CHO DP-12 cells had an average methylation level of 61%. As
global methylation levels of >70% were reported for a wide variety
of cells (e.g. 82% methylation for HUES64 cells or 78% methylation
for fetal brain cells) (Ziller et al., 2013), this ﬁnding suggests hypo-
methylation for the samples analyzed. A global analysis of DNA
methylation on the level of single CpG dinucleotides showed a gen-
erally bimodal distribution of methylation with 52% of all CpGs
being largely methylated (>70% of reads showing methylation) and
30% of unmethylated CpGs (≤10% of reads showing methylation)
(Fig. 2A). The remainder of CpG dinucleotides showed partial meth-
ylation.
To get an initial overview of the CHO DP-12 cell DNA meth-
ylation landscape, we examined whether the observed overall
hypomethylation was due to a uniform distribution of CpGs with
low and high methylation levels or if there were local differences in
average methylation between genomic regions. Therefore, the dis-
tribution of average methylation levels for non-overlapping 20 kb
windows tiled through the genome was  analyzed (according to
Schroeder et al., 2011). Windows containing less than 100 CpGs
were excluded from the analysis. The purpose of this calcula-
tion was to diminish the effect of putatively unmethylated CpG
islands. This analysis showed a very broad methylation spectrum
between 20% and 80% methylation with a peak at 60%, indicating a
high degree of heterogeneity in local CHO DP-12 DNA  methylation
(Fig. 2B).
To further characterize the CHO DP-12 cell methylome with
regard to the methylation of annotated genomic features, DNA
methylation levels for CGIs, untranslated regions (UTRs), coding
sequences (CDSs) and introns (CDS and introns also referred to as
gene-bodies) were determined (Fig. 2C). 45% of all CGIs in the CHO
DP-12 cell genome proved to be unmethylated and CGIs showed a
mean methylation level of 45%. UTRs showed a mean methylation
of 56%, with 26% of them being unmethylated. CDSs and intronic
regions exhibited mean methylation levels of 76% and 68%, respec-
tively, a low percentage of unmethylated regions (9% and 7%) and
a high frequency of highly methylated regions.
In summary, CHO DP-12 cells showed hypomethylation and
evidence for local differences in average methylation levels. In
accordance with previously described DNA methylomes, CGIs
A. Wippermann et al. / Journal of Biotechnology 199 (2015) 38–46 41
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he  CHO DP-12 genome. (C) Percent methylation of CpG islands (CGIs), untranslated
f  regions with methylation levels below 10%. Also indicated is the average methyl
roved to have the lowest methylation levels, although a larger
raction of them was methylated as e.g. in comparison to CGIs in
uman tissues (9% of hypermethylated CGIs) (Eckhardt et al., 2006).
ene-bodies in CHO DP-12 cells exhibited a higher level of DNA
ethylation than UTRs.
.3. Evidence for partially methylated domains in the CHO DP-12
enome
As we found indications of heterogeneous DNA methylation pat-
erns in the CHO DP-12 cell genome, we plotted methylation levels
long the SNP-corrected CHO K1 scaffolds to visualize their dis-
ribution. In this analysis we observed heterogeneous patterns of
NA methylation with regions showing a high degree of methyla-
ion and neighboring regions with partial methylation (exemplarily
hown in Fig. 3 and Supplementary Fig. S2). Similar patterns of
lternating methylation domains were e.g. found in colorectal
ancer, breast cancer, ﬁbroblast cultures, SH-SY5Y neuronal cells
nd placenta. Regions with partial methylation in these cells and
2500 3000 3500 4000
CGI
Exon
PMD
Meth level
[kb]
Partial sequenc e of scaffold JH000005
ig. 3. Exemplary display of 3750 kb of SNP-corrected CHO K1 scaffold JH000005. CHO D
olor-coded according to the legend. Also shown are exons and CpG islands (CGI) in black. 
H000001 to JH000009 are shown in Supplementary Figure S2. (For interpretation of the 
rticle.)cleotides. (B) Percent methylation of 20 kb, non-overlapping windows tiled through
s (UTRs), coding sequences (CDSs) and introns. Lightgrey bars mark the percentage
evel of each genomic feature.
tissues were termed partially methylated domains (PMDs)
(Schroeder et al., 2011, 2013; Gaidatzis et al., 2014; Lister et al.,
2009; Hon et al., 2012; Berman et al., 2012). Accordingly, we  classi-
ﬁed regions with a minimum size of 10 kb and a methylation level
below 70% as CHO DP-12 PMDs. Calculation of the PMD-coverage of
all SNP-corrected CHO K1 scaffolds with more than 100 CpGs (4874
scaffolds comprising 96% of the CHO genome) showed that 62% of
the analyzed scaffolds were partially methylated. Accordingly, 38%
of the CHO DP-12 cell genome were covered by highly methylated
domains (HMDs).
As it was  shown that X chromosome inactivation complicates
PMD  analyses (Schroeder et al., 2011) and due to the fact that CHO
cells originate from a female donor, we next asked whether CHO
DP-12 PMDs showed differences in their distribution on the sin-
gle chromosomes. We checked for this possibility by mapping the
whole genome bisulﬁte sequencing reads to the Chinese hamster
(CH) chromosomes sequenced and annotated by Brinkrolf et al.
(2013). Normalized to chromosome size, we detected on average
18.4 PMDs/Mb and a very signiﬁcant difference in PMD  count per
4500 5000 5500 6000
>80%>60-80%0-60%
Color coding of methylation level
P-12 DNA methylation levels for 1 kb windows were plotted along the scaffold and
Regions identiﬁed as CHO DP-12 PMDs are marked by blue bars. Complete scaffolds
references to color in ﬁgure legend, the reader is referred to the web version of the
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Table  1
Gene ontology (GO) classiﬁcation of total CHO DP-12 PMD-genes (4265) with Benjamini p values < 0.05.
GO term (category ‘biological process’) % Fold enrichment p Value Benjamini p value
Translational elongation 1.7 3.07 5.59 × 10−29 2.86 × 10−25
Translation 3.6 1.96 1.96 × 10−22 5.01 × 10−19
Sensory perception of smell 4.3 1.80 5.95 × 10−21 1.02 × 10−17
Sensory perception of chemical stimulus 4.6 1.71 3.16 × 10−19 4.05 × 10−16
Neurological system process 9.1 1.35 1.31 × 10−13 1.35 × 10−10
Cognition 7.2 1.41 2.90 × 10−13 2.48 × 10−10
Sensory perception 6.5 1.43 6.29 × 10−13 4.60 × 10−10
G-protein coupled receptor protein signaling pathway 8.1 1.28 8.68 × 10−9 5.56 × 10−6
Ribosome biogenesis 1.3 1.88 9.95 × 10−8 5.66 × 10−5
Ribonucleoprotein complex biogenesis 1.7 1.64 1.67 × 10−6 8.54 × 10−4
ncRNA processing 1.7 1.60 4.47 × 10−6 0.002
rRNA processing 1.0 1.87 5.89 × 10−6 0.003
ncRNA metabolic process 2.0 1.52 8.94 × 10−6 0.004
rRNA metabolic process 1.0 1.80 2.28 × 10−5 0.008
RNA  splicing, via transesteriﬁcation reactions 1.4 1.60 3.19 × 10−5 0.011
RNA  splicing, via transesteriﬁcation reactions with
bulged adenosine as nucleophile
1.4 1.60 3.19 × 10−5 0.011
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RNA  processing 3.9 
b  for chromosome X, which was much higher with 26.4 PMDs/Mb
Supplementary Fig. S3). A similar ﬁnding was reported by Lister
t al. (2009) for IMR90 PMDs. Therefore, PMDs on the X chromo-
ome were omitted from further analyses of PMD  and HMD  size,
ethylation level and coding sequence (CDS) coverage.
CHO DP-12 PMDs exhibited 54% methylation on average, a mean
ize of 64 kb and a maximum size of 2990 kb (Fig. 4A and B). In con-
rast, HMDs showed a mean methylation of 77%, a mean size of
4 kb and a maximum size of 450 kb. Next, we calculated the cov-
rage of CHO DP-12 PMDs and HMDs by coding sequence (Fig. 4C).
HO DP-12 PMDs showed a mean CDS coverage of 1.8% and a
aximum coverage of 65%, whereas HMDs exhibited a mean CDS
overage of 3.4% and a maximum coverage of 90%. In order to fur-
hermore obtain the number of CHO DP-12 PMD-localized genes,
e categorized all annotated CHO genes according to their genomic
osition within or outside of a CHO DP-12 PMD. Genes with par-
ial PMD coverage were excluded. 4265 unique genes co-localized
ith a CHO DP-12 PMD, representing only 18% of the total of 24,383
enes predicted for the CHO K1 cell line (Xu et al., 2011). In sum-
ary, CHO DP-12 PMDs proved to be larger but also showed clear
vidence for containing fewer genes than CHO DP-12 HMDs.
.4. Functional classiﬁcation of genes within CHO DP-12 partially
ethylated domains
In a next step, we examined PMD-gene expression in our sam-
les using a CHO-speciﬁc microarray (Becker et al., 2014), as a
nown characteristic of PMDs is transcriptional repression of co-
ocalized genes. This microarray enabled the analysis of 16,693
nique gene clusters and covered 85% of the identiﬁed CHO DP-
2 PMD-genes. The remaining (635) PMD-genes were not present
n the microarray and were therefore not analyzed (Fig. 4D). As we
pplied a one-color labeling protocol, an estimation of gene expres-
ion strengths was possible by this experiment and allowed for the
dentiﬁcation of the subset of genes that were highly expressed.
y this means, 3120 highly expressed genes were identiﬁed and
0% (1261) of them also belonged to the CHO DP-12 PMD-localized
enes.
Interestingly, Gene Ontology (GO) analysis of the total 4265
enes associated with a CHO DP-12 PMD  showed signiﬁcant enrich-
ent of two different general categories. These genes were on
he one hand related to gene expression (RNA metabolism and
ranslation) and on the other hand related to neurological pro-
esses (Table 1). When we performed separate GO annotations1.60 3.19 × 10 0.011
1.27 1.25 × 10−4 0.039
for the highly expressed PMD-genes (1261) and the weakly or
not expressed PMD-genes (2360), respectively, we  found that the
highly expressed PMD-genes mainly belonged to GO classes with
functions related to gene expression (Table 2 and Supplementary
Table S1). Additionally, genes contributing to energy metabolism
and cell cycle control were enriched. Within the weakly or not
expressed PMD-genes those contributing to neurological processes
were overrepresented (Table 3 and Supplementary Table S3). Also,
genes with functions in cellular adhesion and calcium ion homeo-
stasis were signiﬁcantly enriched in this group.
4. Discussion
4.1. The CHO DP-12 cell DNA methylome is characterized by
global hypomethylation and hypermethylation of CpG islands
This study provides the ﬁrst genome-wide, single-base DNA
methylation map  of a CHO cell genome in combination with a
functional assessment of its inﬂuence on gene expression. To exem-
plarily examine DNA methylation patterns and gene expression of
viable, antibody-producing CHO cells, we analyzed samples of four
replicate CHO DP-12 cell batch cultures in the exponential growth
phase by whole genome bisulﬁte sequencing. We  show that the
CHO DP-12 cell genome is hypomethylated (61% CpG methylation)
compared to most mammalian cell types like embryonic stem (ES)
cells, their derivatives and primary cells that exhibit global methyl-
ation levels of >70% (Ziller et al., 2013). Global hypomethylation has
been reported for cancers such as colon tumors and also for long-
term cultured cells like IMR90, foreskin ﬁbroblasts and HepG2 cells
and proved to be either related to a uniform or a locally concen-
trated distribution of hypomethylated regions (Ziller et al., 2013;
Laurent et al., 2010; Berman et al., 2012; Schroeder and LaSalle,
2013).
The analysis of methylation of genomic features showed that
CGIs and UTRs in CHO DP-12 cells are less frequently methyl-
ated than so-called gene bodies (coding sequences and introns)
that are predominantly methylated. This is in accordance with
previously described DNA methylomes that show higher levels of
DNA methylation in gene-bodies compared to UTRs. This was e.g.
shown in bovine muscle tissue (Huang et al., 2014). For multi-
ple species a genome-wide negative correlation between promoter
methylation and gene expression was described, whereas gene-
body methylation has been reported to be positively correlated
with gene expression (Deaton and Bird, 2011; Jjingo et al., 2012).
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Fig. 4. Characterization of CHO DP-12 partially methylated domains (PMDs) and highly methylated domains (HMDs). (A–C) Mean values of data are indicated by black
circles. Outliers are not shown. (A) Percent methylation. (B) Size in kilobasepairs (kb). (C) Coding sequence (CDS) coverage. (D) 4265 genes co-localized with CHO DP-12
PMDs.  Microarray analysis enabled assessment of the expression levels of 16,693 genes. Of these, 3120 were highly expressed. 1261 of the highly expressed genes also
co-localized with CHO DP-12 PMDs.
Table 2
Gene ontology (GO) classiﬁcation of highly expressed CHO DP-12 PMD-genes (1261) with Benjamini p values < 0.05. Displayed are the top 20 GO terms according to p values.
A  complete list can be found in Supplementary Table SI.
GO term (category ‘biological process’) % Fold enrichment p Value Benjamini p value
Translation 11.7 5.78 4.54 × 10−76 1.41 × 10−72
Translational elongation 6.1 9.92 7.25E × 10−64 1.13 × 10−60
RNA processing 9.3 2.78 6.47 × 10−25 6.72 × 10−22
Ribosome biogenesis 4.0 5.33 1.14 × 10−23 8.88 × 10−21
Ribonucleoprotein complex biogenesis 4.8 4.34 6.73 × 10−23 4.19 × 10−20
Nuclear mRNA splicing, via spliceosome 4.0 4.25 9.30 × 10−19 4.83 × 10−16
RNA splicing, via transesteriﬁcation reactions 4.0 4.25 9.30 × 10−19 4.83 × 10−16
RNA splicing, via transesteriﬁcation reactions with
bulged adenosine as nucleophile
4.0 4.25 9.30 × 10−19 4.83 × 10−16
rRNA processing 2.9 5.23 2.61 × 10−17 1.16 × 10−14
RNA splicing 5.4 3.11 2.84 × 10−17 1.11 × 10−14
rRNA metabolic process 2.9 5.01 1.31 × 10−16 3.84 × 10−14
mRNA processing 5.6 2.84 2.09 × 10−15 6.57 × 10−13
Oxidative phosphorylation 2.9 4.78 2.32 × 10−15 6.60 × 10−13
ncRNA metabolic process 4.4 3.17 1.47 × 10−14 3.83 × 10−12
Generation of precursor metabolites and energy 5.2 2.74 7.95 × 10−14 1.91 × 10−11
mRNA metabolic process 5.8 2.57 1.12 × 10−13 2.50 × 10−11
ncRNA processing 3.7 3.27 7.37 × 10−13 1.53 × 10−10
Energy coupled proton transport, down
electrochemical gradient
1.4 5.85 1.61 × 10−9 3.14 × 10−7
ATP synthesis coupled proton transport 1.4 5.85 1.61 × 10−9 3.14 × 10−7
Ribosomal small subunit biogenesis 0.8 11.83 4.30 × 10−9 7.88 × 10−7
Mitotic cell cycle 4.9 2.18 8.82 × 10−9 1.53 × 10−6
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Table  3
Gene ontology (GO) classiﬁcation of weakly or not expressed CHO DP-12 PMD-genes (2360) with Benjamini p values < 0.05. Displayed are the top 20 GO terms according to
p  values. A complete list can be found in Supplementary Table SII.
GO term (category ‘biological process’) % Fold enrichment p Value Benjamini p value
Cell adhesion 6.3 1.63 6.01 × 10−10 1.23 × 10−6
Synaptic transmission 3.1 1.85 2.02 × 10−7 2.77 × 10−4
Transmission of nerve impulse 3.4 1.78 2.25 × 10−7 2.31 × 10−4
Behavior 4.2 1.60 1.70 × 10−6 0.001
Elevation of cytosolic calcium ion concentration 1.4 2.37 2.23 × 10−6 0.002
Calcium ion homeostasis 2.1 2.00 2.45 × 10−6 0.001
Neurological system process 9.0 1.34 2.48 × 10−6 0.001
Cellular calcium ion homeostasis 2.0 2.01 2.61 × 10−6 0.001
Cellular di-, tri-valent inorganic cation homeostasis 2.3 1.86 5.97 × 10−6 0.002
Cellular metal ion homeostasis 2.1 1.92 8.43 × 10−6 0.003
Response to wounding 4.5 1.52 8.63 × 10−6 0.003
Cytosolic calcium ion homeostasis 1.4 2.21 1.18 × 10−5 0.004
Cellular chemical homeostasis 3.4 1.62 1.27 × 10−5 0.004
Cellular ion homeostasis 3.4 1.62 1.28 × 10−5 0.003
Metal ion homeostasis 2.1 1.87 1.38 × 10−5 0.004
Di-,  tri-valent inorganic cation homeostasis 2.4 1.80 1.39 × 10−5 0.003
Cell–cell signaling 4.8 1.45 3.90 × 10−5 0.009
Cellular cation homeostasis 2.4 1.72 4.26 × 10−5 0.009
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he meaning of evolutionary conserved gene-body methylation is
ot completely understood yet, but studies indicate that intragenic
NA methylation modulates alternative RNA splicing (Maunakea
t al., 2013). CGIs proved to have the lowest overall methylation
evels in CHO DP-12 cells, although a larger fraction of them is meth-
lated compared to human tissues, mouse embryomic stem cells
r differentiated mouse cells (Eckhardt et al., 2006; Meissner et al.,
008; Stadler et al., 2011). This ﬁnding is in contrast to the concept
f CGIs being usually characterized by their lack of DNA methyla-
ion, but in accordance with the hypothesis that a great number of
GIs become methylated in permanent cell lines (Antequera et al.,
990). Cancer cells are also known to exhibit global hypomethyla-
ion that accompanies aberrant hypermethylation of CGIs (Sproul
nd Meehan, 2013). In many of such cases hypermethylation of pro-
oter CGIs can be related to silencing of tumor suppressor genes
egulating cell growth, differentiation and apoptosis (Yang and
heng, 2014; Liu et al., 2014). Hu et al. (2015), e.g. identiﬁed novel
andidate tumor suppressor genes in natural killer cell lymphoma
NKCL) by promoter methylation analysis and gene expression pro-
ling, including bcl-2-like protein 11 (BCL2L11). Ectopic BCL2L11
xpression led to increased apoptosis in natural killer cell lines. A
imilar approach could be applied to ﬁnd key regulators of growth
nd apoptosis in CHO cells useful for cell line engineering.
.2. The CHO DP-12 cell DNA methylome shows evidence of
artially methylated domains
The global characterization of DNA methylation in the CHO
P-12 cell genome indicated a heterogeneous arrangement of
ypomethylated regions instead of an even distribution. When we
lotted methylation levels along the SNP-corrected CHO K1 scaf-
olds, we observed large genomic regions with partial methylation.
ethylation levels of 54% on average could be assigned to these
egions which clearly separated them from the neighboring regions
ith a mean methylation of 77%. We  termed them CHO DP-12 PMDs
ccording to the PMDs found in colorectal cancer, breast cancer,
broblast cultures, SH-SY5Y neuronal cells and placenta (Schroeder
t al., 2011, 2013; Gaidatzis et al., 2014; Schroeder and LaSalle,
013; Lister et al., 2009; Hon et al., 2012; Berman et al., 2012).
MDs correspond to genomic domains of an average size of 135 kb
hat cover approximately 40% of the above-mentioned genomes
nd have lower levels of DNA methylation than the neighboring
enomic regions (Gaidatzis et al., 2014; Schroeder and LaSalle,1.64 5.03 × 10−5 0.010
1.84 8.70 × 10−5 0.017
2013). For CHO DP-12 PMDs we detected a mean size of 64 kb,
which is probably due to the current draft status of the CHO K1
genome. We  observed a coverage of all analyzed SNP-corrected
CHO K1 scaffolds by CHO DP-12 PMDs of 62%.
Another characteristic of PMDs is transcriptional repression of
genes localized within these regions that are generally gene-poor
(Schroeder et al., 2013). Accordingly, only 18% (4265) of all genes
were located within CHO DP-12 PMDs. However, gene expression
analysis showed that 30% (1261) of the CHO DP-12 PMD-genes were
highly expressed, contradicting the notion of generally repressed
expression of PMD-localized genes. In agreement with the differ-
ences in expression, GO analysis of all genes located within CHO
DP-12 PMDs showed a signiﬁcant enrichment in two  different func-
tional groups that were related to gene expression on the one
hand and to neurological processes on the other hand. When we
performed a separate GO analysis for the highly expressed PMD-
genes, we found a signiﬁcant overrepresentation of those genes
with functions in gene expression and, additionally, in energy
metabolism and cell cycle, thus representing functions vital for
CHO cell growth and productivity. Several reports have shown
strong expression of genes related to transcription, translation,
chromatin modiﬁcation and energy metabolism in CHO cell cul-
tures, too (Carlage et al., 2009; Meleady et al., 2011; Nissom et al.,
2006).
Weakly or not expressed CHO DP-12 PMD genes were signiﬁ-
cantly enriched for the functions related to neurological processes
such as synaptic transmission and also to cell adhesion and calcium
ion homeostasis. It is known that PMDs often contain repressed
genes with tissue-speciﬁc functions unrelated to the tissue of origin
(Schroeder and LaSalle, 2013). Neurological processes clearly are
unnecessary functions in CHO cells. These processes are strongly
related to the cellular calcium homeostasis, as intracellular cal-
cium plays a critical role in neuron development (Gomez and Zheng,
2006). It is striking that reduced capacity of cellular adhesion is rele-
vant for adaption of CHO cells to suspension culture, which is a CHO
cell property necessary for scalability of industrial processes. It is
also strongly related to the conversion of benign tumors to aggres-
sive cancers (Tokuda et al., 2014). Interestingly, PMDs in placenta
tissue, SH-SY5Y and IMR90 cells are most signiﬁcantly enriched
in genes contributing to neurological processes, too (Schroeder
et al., 2013). This ﬁnding is supported by the fact that methylation
patterns in PMDs were shown to be conserved across cell types
(Gaidatzis et al., 2014).
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. Conclusions
This study provides the ﬁrst global analysis of the CHO DNA
ethylation landscape. We  show that the CHO DP-12 cell methy-
ome exhibits general properties that are typical for mammalian
ells, although it also turns out to be heterogeneous and char-
cterized by global hypomethylation and hypermethylation of
pG islands. It furthermore shows strong evidence of partially
ethylated domains. Similar epigenomic features are observed for
any cancer types and also for placenta (Schroeder and LaSalle,
013). In fact, placental trophoblastic and malignant cells share
eatures such as high proliferation or their lack of cell-contact
nhibition and it was shown that a subset of malignant tumors acti-
ate ectopic expression of germline and placental genes (Ferretti
t al., 2006; Rousseaux et al., 2013). CHO cells are, similarly to
ancer and placental trophoblast cells, characterized by their pro-
iferative properties and deregulated apoptotic pathways. Here,
e additionally report that CHO DP-12 cells not only exhibit
pigenomic features similar to cancer and placenta cells, but that
here is evidence of these features being involved in the repres-
ion of tissue-speciﬁc genes, as it was shown for placenta PMDs,
oo. Interestingly, the repressive effect of CHO DP-12 PMDs does
ot affect genes relevant to CHO cell properties. To fully under-
tand this relationship, it still needs to be elucidated how PMDs
volved, if they are generated in a dynamic manner and what
hey look like on the cellular level. A comparison of different CHO
ell lines with respect to the presence and location of PMDs is
lso required. However, our ﬁndings show that DNA methyla-
ion might signiﬁcantly contribute to CHO phenotypes and allow
or a deeper understanding of CHO cell properties. As a conse-
uence, future experiments to identify targets for rational design
f CHO cell lines with improved production characteristics should
ot only address gene expression changes, but also the underly-
ng epigenetic patterns. The presence of PMDs in the CHO DP-12
ell genome for example underlines the necessity of site-speciﬁc
ntegration of recombinant genes in order to avoid potentially
nfavorable epigenetic environments leading to low expression
evels.
cknowledgements
AW acknowledges a scholarship from the CLIB Graduate Cluster
ndustrial Biotechnology. We  thank Andreas Albersmeier and Anika
inkler for expert performance of Illumina sequencing.
ppendix A. Supplementary data
Supplementary data associated with this article can be
ound, in the online version, at http://dx.doi.org/10.1016/j.jbiotec.
015.02.014.
eferences
ndrews, S., 2010. FastQC: A Quality Control tool for High Throughput Sequence
Data. http://www.bioinformatics.babraham.ac.uk/projects/fastqc/
ntequera, F., Boyes, J., Bird, A., 1990. High levels of de novo methylation and altered
chromatin structure at CpG islands in cell lines. Cell 62, 503–514.
aik, J.Y., Lee, K.H., 2014. Toward product attribute control: developments from
genome sequencing. Curr. Opin. Biotechnol. 30C, 40–44.
auer, A.P., Leikam, D., Krinner, S., Notka, F., Ludwig, C., Längst, G., Wagner, R., 2010.
The impact of intragenic CpG content on gene expression. Nucleic Acids Res. 38,
3891–3908.ecker, J., Timmermann, C., Rupp, O., Albaum, S.P., Brinkrolf, K., Goesmann, A., Püh-
ler, A., Tauch, A., Noll, T., 2014. Transcriptome analyses of CHO cells with the
next-generation microarray CHO41K: development and validation by analysing
the inﬂuence of the growth stimulating substance IGF-1 substitute LongR3. J.
Biotechnol. 178, 23–31.technology 199 (2015) 38–46 45
Benjamini, Y., Hochberg, Y., 1995. Controlling the false discovery rate: a practical
and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B: Stat. Methodol.
57,  289–300.
Berman, B.P., Weisenberger, D.J., Aman, J.F., Hinoue, T., Ramjan, Z., Liu, Y., Noush-
mehr, H., Lange, C.P.E., van Dijk, C.M., Tollenaar, R.A.E.M., Van Den Berg, D., Laird,
P.W., 2012. Regions of focal DNA hypermethylation and long-range hypometh-
ylation in colorectal cancer coincide with nuclear lamina-associated domains.
Nat.  Genet. 44, 40–46.
Bestor, T.H., Edwards, J.R., Boulard, M.,  2014. Notes on the role of dynamic DNA
methylation in mammalian development. Proc. Natl. Acad. Sci. U.  S. A., pii:
201415301.
Bolger, A.M., Lohse, M.,  Usadel, B., 2014. Trimmomatic: a ﬂexible trimmer for Illu-
mina sequence data. Bioinformatics 30, 2114–2120.
Brinkrolf, K., Rupp, O., Laux, H., Kollin, F., Ernst, W.,  Linke, B., Koﬂer, R., Romand,
S.,  Hesse, F., Budach, W.E., Galosy, S., Müller, D., Noll, T., Wienberg, J., Jostock,
T.,  Leonard, M.,  Grillari, J., Tauch, A., Goesmann, A., Helk, B., Mott, J.E., Pühler, A.,
Borth, N., 2013. Chinese hamster genome sequenced from sorted chromosomes.
Nat. Biotechnol. 31, 694–695.
Carlage, T., Hincapie, M.,  Zang, L., Lyubarskaya, Y., Madden, H., Mhatre, R., Hancock,
W.S., 2009. Proteomic proﬁling of a high-producing Chinese hamster ovary cell
culture. Anal. Chem. 81, 7357–7362.
Deaton, A.M., Bird, A., 2011. CpG islands and the regulation of transcription. Genes
Dev. 25, 1010–1022.
Eckhardt, F., Lewin, J., Cortese, R., Rakyan, V.K., Attwood, J., Burger, M.,  Burton, J.,
Cox, T.V., Davies, R., Down, T.A., Haeﬂiger, C., Horton, R., Howe, K., Jackson,
D.K., Kunde, J., Koenig, C., Liddle, J., Niblett, D., Otto, T., Pettett, R., Seemann, S.,
Thompson, C., West, T., Rogers, J., Olek, A., Berlin, K., Beck, S., 2006. DNA meth-
ylation proﬁling of human chromosomes 6, 20 and 22. Nat. Genet. 38, 1378–
1385.
Ferretti, C., Bruni, L., Dangles-Marie, V., Pecking, A.P., Bellet, D., 2006. Molecular
circuits shared by placental and cancer cells, and their implications in the proli-
ferative, invasive and migratory capacities of trophoblasts. Hum. Reprod. Update
13, 121–141.
Gaidatzis, D., Burger, L., Murr, R., Lerch, A., Dessus-Babus, S., Schübeler, D., Stadler,
M.B., 2014. DNA sequence explains seemingly disordered methylation lev-
els  in partially methylated domains of Mammalian genomes. PLoS Genet. 10,
e1004143.
Gomez, T.M., Zheng, J.Q., 2006. The molecular basis for calcium-dependent axon
pathﬁnding. Nat. Rev. Neurosci. 7, 115–125.
Holliday, R., Pugh, J.E., 1975. DNA modiﬁcation mechanisms and gene activity during
development. Science 187, 226–232.
Hon, G.C., Hawkins, R.D., Caballero, O.L., Lo, C., Lister, R., Pelizzola, M.,  Valsesia, A.,
Ye,  Z., Kuan, S., Edsall, L.E., Camargo, A.A., Stevenson, B.J., Ecker, J.R., Bafna, V.,
Strausberg, R.L., Simpson, A.J., Ren, B., 2012. Global DNA hypomethylation cou-
pled to repressive chromatin domain formation and gene silencing in breast
cancer. Genome Res. 22, 246–258.
Hu, X., Kucuk, C., Jiang, B., Klinkebiel, D., Geng, H., Gong, Q., Bouska, A., Iqbal, J.,
Gaulard, P., McKeithan, T.W., Chan, W.C., 2015. Global promoter methylation
analysis reveals novel candidate tumor suppressor genes in natural killer cell
lymphoma. Clin. Cancer Res., pii: clincanres.1216.2014.
Huang, D.W., Sherman, B.T., Zheng, X., Yang, J., Imamichi, T., Stephens, R., Lempicki,
R.A., 2009. Extracting biological meaning from large gene lists with DAVID. Curr.
Protoc. Bioinform., Chapter 13, Unit 13.11.
Huang, Y.-Z., Sun, J.-J., Zhang, L.-Z., Li, C.-J., Womack, J.E., Li, Z.-J., Lan, X.-Y., Lei, C.-Z.,
Zhang, C.-L., Zhao, X., Chen, H., 2014. Genome-wide DNA methylation proﬁles
and  their relationships with mRNA and the microRNA transcriptome in bovine
muscle tissue (Bos taurine). Sci. Rep. 4, 6546.
Illingworth, R.S., Bird, A.P., 2009. CpG islands – ‘a rough guide’. FEBS Lett. 583,
1713–1720.
Jjingo, D., Conley, A.B., Yi, S.V., Lunyak, V.V., Jordan, I.K., 2012. On the presence and
role of human gene-body DNA methylation. Oncotarget 3, 462–474.
Kim, M.,  O’Callaghan, P.M., Droms, K.A., James, D.C., 2011. A mechanistic under-
standing of production instability in CHO cell lines expressing recombinant
monoclonal antibodies. Biotechnol. Bioeng. 108, 2434–2446.
Langmead, B., Salzberg, S.L., 2012. Fast gapped-read alignment with Bowtie 2. Nat.
Methods 9, 357–359, http://dx.doi.org/10.1038/nmeth.1923.
Laurent, L., Wong, E., Li, G., Huynh, T., Tsirigos, A., Ong, C.T., Low, H.M., Kin Sung,
K.W., Rigoutsos, I., Loring, J., Wei, C.-L., 2010. Dynamic changes in the human
methylome during differentiation. Genome Res. 20, 320–331.
Lewis, N.E., Liu, X., Li, Y., Nagarajan, H., Yerganian, G., O’Brien, E., Bordbar, A.,
Roth, A.M., Rosenbloom, J., Bian, C., Xie, M.,  Chen, W.,  Li, N., Baycin-Hizal,
D.,  Latif, H., Forster, J., Betenbaugh, M.J., Famili, I., Xu, X., Wang, J., Pals-
son, B.O., 2013. Genomic landscapes of Chinese hamster ovary cell lines as
revealed by the Cricetulus griseus draft genome. Nat. Biotechnol. 31, 759–
765.
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abeca-
sis,  G., Durbin, R., 2009. The sequence alignment/map format and SAMtools.
Bioinformatics 25, 2078–2079.
Lister, R., Pelizzola, M.,  Dowen, R.H., Hawkins, R.D., Hon, G., Tonti-Filippini, J., Nery,
J.R.,  Lee, L., Ye, Z., Ngo, Q.-M., Edsall, L., Antosiewicz-Bourget, J., Stewart, R., Ruotti,
V., Millar, A.H., Thomson, J.A., Ren, B., Ecker, J.R., 2009. Human DNA  methy-
lomes at base resolution show widespread epigenomic differences. Nature 462,
315–322.
Liu, G., Liu, Y.-J., Lian, W.-J., Zhao, Z.-W., Yi, T., Zhou, H.-Y., 2014. Reduced BMP6
expression by DNA methylation contributes to EMT  and drug resistance in breast
cancer cells. Oncol. Rep. 32, 581–588.
4  of Bio
M
M
M
N
N
O
O
P
R
R
R
S
S6 A. Wippermann et al. / Journal
aunakea, A.K., Chepelev, I., Cui, K., Zhao, K., 2013. Intragenic DNA methylation mod-
ulates alternative splicing by recruiting MeCP2 to promote exon recognition. Cell
Res.  23, 1256–1269.
eissner, A., Mikkelsen, T.S., Gu, H., Wernig, M.,  Hanna, J., Sivachenko, A., Zhang,
X.,  Bernstein, B.E., Nusbaum, C., Jaffe, D.B., Gnirke, A., Jaenisch, R., Lander, E.S.,
2008. Genome-scale DNA methylation maps of pluripotent and differentiated
cells. Nature 454, 766–770.
eleady, P., Doolan, P., Henry, M.,  Barron, N., Keenan, J., O’Sullivan, F., Clarke, C.,
Gammell, P., Melville, M.W.,  Leonard, M.,  Clynes, M.,  2011. Sustained productiv-
ity  in recombinant Chinese hamster ovary (CHO) cell lines: proteome analysis
of the molecular basis for a process-related phenotype. BMC Biotechnol. 11, 78.
dlovu, M.N., Denis, H., Fuks, F., 2011. Exposing the DNA methylome iceberg. Trends
Biochem. Sci. 36, 381–387.
issom, P.M., Sanny, A., Kok, Y.J., Hiang, Y.T., Chuah, S.H., Shing, T.K., Lee, Y.Y., Wong,
K.T.K., Hu, W.-S., Sim, M.Y.G., Philp, R., 2006. Transcriptome and proteome proﬁl-
ing to understanding the biology of high productivity CHO cells. Mol. Biotechnol.
34,  125–140.
sella, M.,  Riba, A., Testori, A., Corà, D., Caselle, M.,  2014. Interplay of microRNA and
epigenetic regulation in the human regulatory network. Front. Genet. 5, 345.
sterlehner, A., Simmeth, S., Göpfert, U., 2011. Promoter methylation and trans-
gene copy numbers predict unstable protein production in recombinant Chinese
hamster ovary cell lines. Biotechnol. Bioeng. 108, 2670–2681.
anning, B., Jaenisch, R., 1996. DNA hypomethylation can activate Xist expression
and silence X-linked genes. Genes Dev. 10, 1991–2002.
iggs, A.D., 1975. X inactivation, differentiation, and DNA methylation. Cytogenet.
Genome Res. 14, 9–25.
ousseaux, S., Debernardi, A., Jacquiau, B., Vitte, A.-L., Vesin, A., Nagy-Mignotte,
H., Moro-Sibilot, D., Brichon, P.-Y., Lantuejoul, S., Hainaut, P., Laffaire, J., de
Reyniès, A., Beer, D.G., Timsit, J.-F., Brambilla, C., Brambilla, E., Khochbin, S.,
2013. Ectopic activation of germline and placental genes identiﬁes aggressive
metastasis-prone lung cancers. Sci. Transl. Med. 5, 186ra66.
upp, O., Becker, J., Brinkrolf, K., Timmermann, C., Borth, N., Pühler, A., Noll, T., Goes-
mann, A., 2014. Construction of a public CHO cell line transcript database using
versatile bioinformatics analysis pipelines. PLOS ONE 9, e85568.
chroeder, D.I., Blair, J.D., Lott, P., Yu, H.O.K., Hong, D., Crary, F., Ashwood, P., Walker,
C.,  Korf, I., Robinson, W.P., LaSalle, J.M., 2013. The human placenta methylome.
Proc. Natl. Acad. Sci. U. S. A. 110, 6037–6042.
chroeder, D.I., LaSalle, J.M., 2013. How has the study of the human pla-
centa aided our understanding of partially methylated genes? Epigenomics 5,
645–654.technology 199 (2015) 38–46
Schroeder, D.I., Lott, P., Korf, I., LaSalle, J.M., 2011. Large-scale methylation domains
mark a functional subset of neuronally expressed genes. Genome Res. 21,
1583–1591.
Smyth, G.K., 2005. Bioinformatics and Computational Biology Solutions Using R and
Bioconductor, Statistics for Biology and Health. Springer-Verlag, New York.
Song, Q., Decato, B., Hong, E.E., Zhou, M.,  Fang, F., Qu, J., Garvin, T., Kessler, M., Zhou,
J.,  Smith, A.D., 2013. A reference methylome database and analysis pipeline to
facilitate integrative and comparative epigenomics. PLOS ONE 8, e81148.
Sproul, D., Meehan, R.R., 2013. Genomic insights into cancer-associated aberrant
CpG island hypermethylation. Brief. Funct. Genomics 12, 174–190.
Stadler, M.B., Murr, R., Burger, L., Ivanek, R., Lienert, F., Schöler, A., van Nimwegen,
E.,  Wirbelauer, C., Oakeley, E.J., Gaidatzis, D., Tiwari, V.K., Schübeler, D., 2011.
DNA-binding factors shape the mouse methylome at distal regulatory regions.
Nature 480, 490–495.
Tessarz, P., Kouzarides, T., 2014. Histone core modiﬁcations regulating nucleosome
structure and dynamics. Nat. Rev. Mol. Cell Biol. 15, 703–708.
Tokuda, E., Itoh, T., Hasegawa, J., Ijuin, T., Takeuchi, Y., Irino, Y., Fukumoto, M.,
Takenawa, T., 2014. Phosphatidylinositol 4-phosphate in the Golgi apparatus
regulates cell–cell adhesion and invasive cell migration in human breast cancer.
Cancer Res. 74, 3054–3066.
Walsh, C.P., Chaillet, J.R., Bestor, T.H., 1998. Transcription of IAP endogenous retro-
viruses is constrained by cytosine methylation. Nat. Genet. 20, 116–117.
Wippermann, A., Klausing, S., Rupp, O., Albaum, S.P., Büntemeyer, H., Noll, T., Hof-
frogge, R., 2013. Establishment of a CpG island microarray for analyses of
genome-wide DNA methylation in Chinese hamster ovary cells. Appl. Microbiol.
Biotechnol. 98, 579–589.
Xu, X., Nagarajan, H., Lewis, N.E., Pan, S., Cai, Z., Liu, X., Chen, W.,  Xie, M.,  Wang, W.,
Hammond, S., Andersen, M.R., Neff, N., Passarelli, B., Koh, W.,  Fan, H.C., Wang, J.,
Gui,  Y., Lee, K.H., Betenbaugh, M.J., Quake, S.R., Famili, I., Palsson, B.O., Wang, J.,
2011. The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line.
Nat.  Biotechnol. 29, 735–741.
Yang, W.-T., Zheng, P.-S., 2014. Promoter hypermethylation of KLF4 inactivates its
tumor suppressor function in cervical carcinogenesis. PLOS ONE 9, e88827.
Yang, Y., Chusainow, J., Yap, M.G.S., 2010. DNA methylation contributes to loss in
productivity of monoclonal antibody-producing CHO cell lines. J. Biotechnol.
147, 180–185.
Ziller, M.J., Gu, H., Müller, F., Donaghey, J., Tsai, L.T.-Y., Kohlbacher, O., De Jager,
P.L., Rosen, E.D., Bennett, D.A., Bernstein, B.E., Gnirke, A., Meissner, A., 2013.
Charting a dynamic DNA methylation landscape of the human genome. Nature
500, 477–481.
